Another study showed that inhibition of endogenous neurotrophic tyrosine receptor kinase (TrkB) signaling by treatment with either the soluble TrkB ectodomain or the Trk receptor inhibitor K252a suppressed uterine sarcoma cell proliferation and increased apoptosis [101]. The gene discussed is NTRK2; the disease is uterine corpus sarcoma.